JACOBS LEVY EQUITY MANAGEMENT, INC
Position in RCUS — Arcus Biosciences, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,787,549
+$6,492,076 QoQ
Shares Held
512,084
+19.0% QoQ
Ownership
0.402%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#35
of 230 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. RCUS ranks #9 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in RCUS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,787,549 | 512,084 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,295,473 | 430,346 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,161,447 | 929,981 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,232,843 | 1,120,062 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $6,555,182 | 805,305 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,631,432 | 972,157 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,928,376 | 465,304 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $359,549 | 23,608 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $5,019,690 | 262,811 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,496,109 | 139,059 | Shares | Sole | 2023-11-17 | |
| 2020-03-31 | $308,066 | 22,195 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||